These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 614450)

  • 21. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)].
    Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K
    Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
    Kashiwagi T; Azuma M; Matsuda H; Yoshioka H; Ishizu H; Mitsutani N; Koizumi T; Kobayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2061-7. PubMed ID: 2419606
    [No Abstract]   [Full Text] [Related]  

  • 23. Quest for the perfect hepatobiliary radiopharmaceutical.
    Fritzberg AR; Klingensmith WC
    J Nucl Med; 1982 Jun; 23(6):543-6. PubMed ID: 6896213
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis of liver tumor using 99mTc-pyridoxylideneisoleucine scintigraphy (author's transl)].
    Kumano M; Matsuo T; Kuriwaki T; Narabayashi K
    Radioisotopes; 1978 Mar; 27(3):157-9. PubMed ID: 208104
    [No Abstract]   [Full Text] [Related]  

  • 25. [Traumatic bile leakage demonstrated by hepatobiliary scintigraphy--a case report].
    Matsuo Y; Shiozaki H; Baba H; Kishikawa T; Hidaka K; Fujiwara H; Harada S; Hisatsugu T
    Kaku Igaku; 1985 Oct; 22(10):1551-5. PubMed ID: 4094176
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation on hepatobiliary scintigraphy with 99mTc(Sn)-N-pyridoxyl-5-methyltryptophan.
    Yamashita M; Watanabe A; Miyazaki T; Nakajima E; Okuno T
    Radioisotopes; 1982 Dec; 31(12):657-9. PubMed ID: 7170355
    [No Abstract]   [Full Text] [Related]  

  • 27. Tc-99m(Sn) pyridoxylideneaminates: preparation and biologic evaluation.
    Kato M; Hazue M
    J Nucl Med; 1978 Apr; 19(4):397-406. PubMed ID: 632929
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance of 99mTc-pyridoxylideneglutamate cholescintigraphy in the biliary tract diseases (author's transl)].
    Tanimura H; Mukaihara S; Maruyama K; Takenaka M; Kobayashi N; Setoyama M; Kamata T; Nagase M; Hikasa Y; Odori T; Morita R; Torizuka K
    Nihon Geka Hokan; 1978 Mar; 47(2):199-208. PubMed ID: 666501
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatobiliary scintigraphy of bronchi-biliary fluids].
    Fujii H; Nishiguchi I; Kubo A
    Rinsho Hoshasen; 1987 Oct; 32(10):1137-8. PubMed ID: 3444077
    [No Abstract]   [Full Text] [Related]  

  • 31. [The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
    Hayakawa T; Katagiri K; Shiraka S; Nakai T; Takeshima A; Kawamura Y; Ohnishi H; Hoshino M; Tsukada K; Miyani M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2389-95. PubMed ID: 3221493
    [No Abstract]   [Full Text] [Related]  

  • 32. [Basic and clinical evaluation of 99mTc-labeled hepatobiliary rn scanning agents. Part I. Basic evaluation (author's transl)].
    Kawaguchi S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Mar; 78(3):701-7. PubMed ID: 6894772
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preparation of 99mTc-Sn-N-(2,6-diethylacetanilido)-imidodiacetate from ROTOP-EHIDA].
    Berger R; Syhre R
    Radiobiol Radiother (Berl); 1986; 27(6):727-32. PubMed ID: 3575680
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy].
    Imai Y
    Kaku Igaku; 1994 Mar; 31(3):249-56. PubMed ID: 8176863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of 99mTc-pyridoxylikeneisoleucine in liver disease (author's transl)].
    Tanaka T; Nanjo T; Nagase K; Arakawa Y; Tanaka M; Iida S; Mori K
    Radioisotopes; 1978 Dec; 27(12):734-6. PubMed ID: 746178
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Tc-99m pyridoxal-phenylalanine as a hepatobiliary imaging agent. Part 1. Experimental studies.
    Fotopoulos A; Chiotelis E; Koutoulidis C; Dassiou A; Papadimitriou J
    J Nucl Med; 1977 Dec; 18(12):1189-93. PubMed ID: 606742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorbed dose estimation of some 99mTc-hepatobiliary agents.
    Koutoulidis C; Chiotellis E; Lymberis C
    Eur J Nucl Med; 1979 Dec; 4(6):441-4. PubMed ID: 520358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatobiliary scintigraphy and liver function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT)].
    Sugimura K; Narabayashi I; Nabeshima K; Ishido N; Hashimoto K; Yamasaki K; Hamada T; Sugimura C; Suematsu T; Inoue Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1205-13. PubMed ID: 6672750
    [No Abstract]   [Full Text] [Related]  

  • 39. [Usefulness of 99mTc-PMT cholescintigraphy in diagnosis a case of bone metastasis in hepatocellular carcinoma].
    Inoue A; Imaeda T; Yanagawa S; Doi T
    Rinsho Hoshasen; 1989 Aug; 34(8):901-2. PubMed ID: 2555595
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatobiliary scintigraphy using 99mTc-pyridoxylideneisoleucine (author's transl)].
    Onishi R; Matsumoto A; Kaino Y; Kochi H; Ito K; Matsuo M; Nishiyama S
    Radioisotopes; 1978 Jun; 27(6):326-9. PubMed ID: 684233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.